Akebia Therapeutics
AKBA
AKBA
157 hedge funds and large institutions have $394M invested in Akebia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
10% more funds holding
Funds holding: 143 → 157 (+14)
4.67% more ownership
Funds ownership: 36.56% → 41.23% (+4.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
157
Holding in Top 10
1
Calls
$2.19M
Puts
$1.51M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$10.5M | |
| 3 | +$9.68M | |
| 4 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
+$8.58M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.01M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$5.62M | |
| 3 | -$5.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.84M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.5M |
